Accounts for 30% of lung cancer patients with bone metastasis harbor activating KRAS mutations.7,8KRAS mutation is the primary cause of the markedly worse outcomes in lung cancer bone metastasis cases. This evidence concerns the gene KRAS and lung cancer.